Valion Bio, Inc.

NASDAQ:VBIO
Annual Meeting

of Shareholders

MEETING DATE

11/12/2026
DEF 14A FILED
10/16/2026
PUBLISHED
10/16/2026 8:48 pm
TIME TO PUBLISH
10/18/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:VBIO · CUSIP 888705100 · CLASS Common Stock · CIK 0001787740

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
1
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To grant discretionary authority to our board of directors (the “Board”) to amend our amended and restated certificate of incorporation to effect a reverse stock split of all of our issued and outstanding shares of common stock at a ratio of not less than 1-for-2 and not greater than 1-for-12, such ratio to be determined by our Board at any time within twelve months from the date that stockholder approval is obtained, without further approval or authorization of our stockholders
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states increased authorized but unissued shares could help management resist a takeover bid favored by independent stockholders.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve an amendment to our Amended and Restated 2021 Equity Incentive Plan (as amended, the “2021 Plan”), to increase the number of shares of common stock authorized for issuance thereunder by 272,000 shares, pursuant to the terms and conditions of the 2021 Plan
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states only approximately 114,121 shares were available for future awards under the 2021 Plan.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To consider and vote upon a proposal to authorize our Board, in its discretion, to adjourn the Special Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the proposals listed above at the time of the Special Meeting
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states adjournment would permit further solicitation of proxies in favor of Proposals 1 and 2.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

405daaac1f4d6dd8d2e536a8746db6f4c897dc2859ba33b27343f61f2758c1c6

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates